Evidence map›Paper›PMID 31873864›Full record

SynthesisEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020

Blastocystis, urticaria, and skin disorders: review of the current evidences.

Fares Bahrami, Erfan Babaei, Alireza Badirzadeh, Tahereh Rezaei Riabi, Amir Abdoli

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Genetic diversity and zoonotic transmission potential ofParasite epidemiology and control · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Antiprotozoal Effects ofPathogens (Basel, Switzerland) · 2025
    Article
  9. Article
  10. The Role ofPathogens (Basel, Switzerland) · 2025
    Review
  11. Article
  12. Effect ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Article
  13. Article
  14. Microorganisms · 2024
    Review
  15. Article
  16. Molecular Identification and Genotyping ofAnimals : an open access journal from MDPI · 2023
    Article
  17. Article
  18. First detection ofOne health (Amsterdam, Netherlands) · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Fares BahramiZoonoses Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Erfan BabaeiDepartment of Immunology & Hematology, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Alireza BadirzadehDepartment of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Tahereh Rezaei RiabiDepartment of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amir AbdoliDepartment of Parasitology and Mycology, Jahrom University of Medical Sciences, Jahrom, Iran. a.abdoli25@gmail.com.ORCID http://orcid.org/0000-0003-4326-4586
Kurdistan University of Medical Sciences · IRIran University of Medical Sciences · IRJahrom University · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blastocystis is one of the most common intestinal protozoan parasites worldwide, which is linked to cutaneous lesions and urticaria. In a setting of systematic review, the data on the association of Blastocystis infection with cutaneous lesions were searched in order to summarize the main clinical symptoms, diagnostic methods, treatment, and outcome of the patients. The search identified 28 eligible articles, including 12 cross-sectional studies and 16 case reports/case series (including 23 cases). A diverse spectrum of skin symptoms, mainly urticaria, rash, and itching, was reported from the studies. Of the 23 infected cases with the skin symptoms, gastrointestinal symptoms were reported from the 16 cases, whereas 7 cases with urticaria had asymptomatic infection. The most frequent subtypes were ST1, ST2, and ST3, respectively. Metronidazole, paromomycin, and tinidazole were the most prescribed drugs in patients with single Blastocystis infection. Notably, urticaria and other cutaneous symptoms of all treated patients were resolved after treatment. In conclusion, this study indicates that Blastocystis infection can be a neglected cause of urticaria and skin disorders. Since the treatment of Blastocystis infection is simple, screening and treatment of this infection should be considered in patients with urticaria and other skin disorders.

Indexed as

Antiprotozoal AgentsAsymptomatic InfectionsBlastocystisBlastocystis InfectionsGenetic VariationHumansIntestinal Diseases, ParasiticSkin DiseasesTreatment OutcomeUrticariaAntiprotozoal AgentsBlastocystisCutaneous lesionsSkin disordersUrticaria

Identifiers

PMID31873864
OpenAlexW2998636690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.